Private company

IBSA Institut Biochimique

Logo: Unknown author Unknown author, Public domain, via Wikimedia Commons3

IBSA Institut Biochimique is a company based in Massagno founded in 1945.1

Die IBSA Institut Biochimique SA mit Sitz in Massagno ist ein international tätiges Schweizer Pharmaunternehmen. Die Schweizer Aktiengesellschaft entwickelt, produziert und vertreibt Wirkstoffe und Medikamente in den Bereichen Sterilitätsbehandlung, Rheumatologie, Sportmedizin, Dermatologie und Pneumologie. Das IBSA Institut Biochimique beschäftigt sich zunehmend mit der Entwicklung von pharmakotherapeutischer Systemen mit komplexen Wirkmechanismen, die formulierungstechnisch anspruchsvolle Darreichungsformen benötigen.2 From the German Wikipedia, CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

1945Founded1
  • HeadquartersMassagno1
  • Websitewww.ibsa.ch
  • Legal formAktiengesellschaft1

Timeline

  1. 1945Founded Founded1

Calendar

Drug trials and FDA: coming up

  1. Jun 30, 2027Phase 3 trial readout expected Phase 3 trial of Sodium hyaluronate solution - 3.36% and Sterile buffered solution in Osteo Arthritis of the Knee: primary completion expected Jun 30, 2027 (ClinicalTrials.gov NCT07819461).4

Drug trials and FDA: recently

  1. Jan 20, 2026Phase 3 trial completed Phase 3 trial of Progesterone-IBSA Injectable Solution and Progesterone Vaginal Gel with Applicator in Infertility: primary completion Jan 20, 2026, no results posted yet (ClinicalTrials.gov NCT04549116).5
  2. Jun 30, 2024Phase 3 trial completed Phase 3 trial of Licart™ (diclofenac epolamine) topical system in Soft Tissue Injuries: primary completion Jun 30, 2024, results posted Sep 30, 2026 (ClinicalTrials.gov NCT05171673).6

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). Trials from ClinicalTrials.gov, as the sponsor registered them (expected dates are the sponsor's own and often move); approvals and advisory committee meetings from the FDA. The FDA does not publish its decision (PDUFA) dates. The full markets calendar